Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v19-FR | Version v16-EN | |
---|---|---|
Language | French | English |
Date Updated | 2019-01-09 | 2018-12-11 |
Drug Identification Number | 02237548 | 02237548 |
Brand name | TWINRIX JUNIOR | TWINRIX JUNIOR |
Common or Proper name | Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine | Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine |
Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
Ingredients | HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN | HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN |
Strength(s) | 360UNIT 10MCG | 360UNIT 10MCG |
Dosage form(s) | SUSPENSION | SUSPENSION |
Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
Packaging size | 1's | 1's |
ATC code | J07BC | J07BC |
ATC description | VIRAL VACCINES | VIRAL VACCINES |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2018-05-03 | 2018-05-03 |
Estimated end date | 2019-01-11 | 2019-01-11 |
Actual end date | 2019-01-07 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | Demand increase coupled with disruption of the manufacture of the drug. | Demand increase coupled with disruption of the manufacture of the drug. Supply unavailable in the private market. Supply available for public programs. |
Health Canada comments |